31 Recruiting Trials

Clinical Trials
for Kidney Disease in Minnesota

31 clinical trials for Kidney Disease are currently recruiting participants at study sites in Minnesota. Study-related care is provided at no cost.

31
Recruiting trials
22
Study sites
7
Cities
19
Industry-sponsored
7
Phase 2
10
Phase 3

Kidney Disease clinical trials in Minnesota: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Minnesota, recruiting kidney disease studies are concentrated in Rochester, Minneapolis, Edina and Duluth, with sites in 3 other cities. 19 of the 31 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 20 of 31 recruiting Kidney Disease trials in Minnesota

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
PHASE3 Huntsville, Alabama +4 sites NCT06531824
This trial is looking for adults with chronic kidney disease who are at risk of it getting worse. Participants will take a study medicine called BI 690517 along with empagliflozin or just empagliflozin for the study duration.
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3 Birmingham, Alabama +4 sites NCT07107945
This trial is looking for children aged 2 to 17 who have chronic kidney disease. Participants will take a daily tablet for 6 months followed by 1 year of another medication, with regular check-ups to monitor their health.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
PHASE1 Saint Paul, Minnesota +4 sites NCT07024823
This trial is looking for healthy individuals and those with chronic kidney disease and type 2 diabetes. Participants will take doses of AZD4248 and may also track their kidney function at home.
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
PHASE2 Decatur, Alabama +4 sites NCT05485961
This trial is looking for adults with end stage kidney disease who are undergoing dialysis and have systemic inflammation. Participants will receive a study medication or a placebo to see how it affects heart health.
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT05312879
This trial is looking for adults and children with a specific type of kidney disease caused by genetics. Participants will receive the drug VX-147 to assess its effectiveness and safety.
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PHASE2 Birmingham, Alabama +4 sites NCT06902558
This trial is looking for adults with a specific type of kidney disease. Participants will receive either the study drug or a placebo every 4 weeks for 92 weeks and will attend regular check-ups.
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
PHASE2 Decatur, Alabama +4 sites NCT06830629
This trial is looking for adults with a specific genetic risk for kidney disease and ongoing protein in their urine. Participants will take the drug MZE829 to see how it affects their kidney condition.
Recruiting
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT06824987
This trial is looking for adults of African descent with a specific type of kidney disease. Participants will take the drug AZD2373 and attend check-ups to see how well the treatment works and if it is safe.
Recruiting
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
PHASE1 Birmingham, Alabama +4 sites NCT07228364
This trial is looking for adults with a specific type of kidney disease who can receive a new treatment called AZD1613. Participants will either receive the treatment through an injection under the skin or directly into the bloodstream and will be monitored for safety and how the body processes the drug.
Recruiting
Managing Depressive Symptoms in ADPKD
NA Rochester, Minnesota NCT07745920
Recruiting
NOX4 and Related Biomarkers in ADPKD
N/A Rochester, Minnesota NCT04630613
This trial is looking for people with a specific type of kidney disease to help determine how certain markers can show how severe their condition is. Participants will need to provide consent and meet certain health criteria.
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
PHASE3 Birmingham, Alabama +4 sites NCT06963827
This trial is looking for adults with a kidney condition called IgA nephropathy. Participants will receive either mezagitamab or a placebo for 22 weeks and then be monitored for about 1.5 years.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Long Beach, California +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA Duluth, Minnesota +4 sites NCT06906627
This trial is looking for adults with type 2 diabetes to improve kidney screening. Participants will need to have had a visit with their primary doctor in the last two years and haven't had certain kidney tests in the past 15 months.
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NA Duluth, Minnesota +4 sites NCT06906640
This trial is looking for adults with type 2 diabetes who have been diagnosed with chronic kidney disease. Participants will receive improved care and management for their kidney health through this program.
Recruiting
Concomitant Renal and Urinary Bladder Allograft Transplantation
EARLY_PHASE1 Rochester, Minnesota +1 sites NCT04626167
This trial is looking for people aged 1 to 60 who have severe bladder issues along with chronic kidney disease. Participants will be evaluated to see if they can safely receive both a kidney and bladder transplant.
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NA Bullhead City, Arizona +4 sites NCT06001827
This trial is looking for adults with chronic kidney disease who need a new arteriovenous fistula for dialysis. Participants will receive a special wrap during the procedure and will follow up with the study team for 36 months.
Recruiting
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
N/A Los Angeles, California +4 sites NCT05106387
This trial is looking for adult patients who have received a kidney transplant and were treated with vonsetamig in a previous study. Participants will be monitored to see how their body responds after the transplant, but no study drug will be given during this trial.
Recruiting

Where the Kidney Disease studies are in Minnesota

  • Mayo Clinic, Rochester7 trials
  • Research Site, Minneapolis3 trials
  • University of Minnesota, Minneapolis3 trials
  • Essentia Health, Duluth2 trials
  • Mayo Clinic in Rochester, Rochester2 trials
  • Minneapolis VA Health Care System, Minneapolis2 trials

Counts are recruiting studies listing at least one site in Minnesota, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Minnesota: common questions

How many Kidney Disease clinical trials are recruiting in Minnesota?
TrialFinder currently lists 31 recruiting Kidney Disease clinical trials with study sites in Minnesota. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Minnesota?
Study sites for the Kidney Disease trials listed on this page include Saint Paul, Rochester, Duluth. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Minnesota?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Minnesota also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Minnesota?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Minnesota.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →